Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06297499 · ClinicalTrials.gov registry record · Phase 1
Ondansetron Use for Preventing Pruritus in Patients Undergoing Cesarean Section
A Phase 1 study of Pruritus Caused by Drug, sponsored by Wayne State University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT06297499 is a Phase 1 study of Pruritus Caused by Drug that is actively recruiting participants, run by Wayne State University. The registered enrollment target is 66 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06297499, a Phase 1 study of Pruritus Caused by Drug, is actively recruiting participants, sponsored by Wayne State University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
Opioids are often added with a local anesthetic to enhance the duration and quality of spinal anesthesia for cesarean delivery patients. However, spinal opioids are associated with a wide variety of side effects such as nausea, vomiting, (N/V) and pruritus (itching). The occurrence of pruritus can vary between 30% and 100% making pruritus the most common side-effect of intrathecal opioids and this rate is even higher in pregnant patients. Pruritus may require treatment which can be ineffective or sometimes reverse the analgesic effect of the opioids. Ondansetron is a safe and very commonly used Serotonin receptor antagonist treatment for local anesthetic opioid-induced pruritus used in pregnancy. The effect of different administration times of ondansetron in reducing pruritus or N/V in cesarean section (CS) cases has not been extensively studied and thus, this prospective study can help guide future clinical management of side effects caused by spinal intrathecal morphine administration.
Conditions Studied
Interventions
- DRUG Ondansetron 8mg
Study Locations (1)
Michigan
- Detroit Medical Center- Hutzel Women's Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2024-08-22 |
| Est. Completion | 2025-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06297499
The ClinicalTrials.gov registry entry for NCT06297499 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pruritus Caused by Drug appearing as the primary indexed condition, and to 1 intervention - of which Ondansetron 8mg is the first listed.
NCT06297499 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT06297499 about?
NCT06297499 is a clinical study titled "Ondansetron Use for Preventing Pruritus in Patients Undergoing Cesarean Section". Opioids are often added with a local anesthetic to enhance the duration and quality of spinal anesthesia for cesarean delivery patients. However, spinal opioids are associated with a wide variety of side effects such as nausea, vomiting, (N/V) and pruritus (itching). The occurrence of pruritus can v...
What is the current status of trial NCT06297499?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 66 participants. The study started on 2024-08-22. Estimated completion is 2025-12-01.
What conditions does trial NCT06297499 study?
This clinical trial studies the following conditions: Pruritus Caused by Drug.
What interventions are being tested in trial NCT06297499?
The interventions under investigation include: Ondansetron 8mg (DRUG).
Who is sponsoring clinical trial NCT06297499?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06297499 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.